Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal midazolam versus ketamine for peripheral IV access in children
IRCT20200728048242N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ketamine and midazolam in intravenous cannulation pain (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: OSBD-R score, Success rate of peripheral IV access and 6 more. Started Jul 2019; status: completed.
02
Drugs
ketaminemidazolam
03
Conditions
intravenous cannulation pain
Beyond the preview
Go deeper on IRCT20200728048242N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200728048242N1.